The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear. Abbott announced that ...

Abbott's FreeStyle Libre Flash glucose monitoring system--Courtesy of Abbott Diabetes care at Abbott Laboratories ($ABT) has returned to sales growth as ex-U.S. sales ...

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater ...

Abbott's FreeStyle Libre Flash glucose monitoring system--Courtesy of Abbott Abbott ($ABT) reported the latest data for its FreeStyle Libre system that doesn't ...

Abbott Labs’ glucose system eliminates the need for routine finger pricks and challenges of routine glucose monitoring for people suffering from diabetes. This enables them to maintain a better ...

The Freestyle Libre 14 day is now the longest-lasting self-applied continuous glucose sensing technology available and allows the used to wear the sensor for up to 14 days with high accuracy. ABBOTT ...

SAN FRANCISCO--(BUSINESS WIRE)--Today, Nutrino, (www.nutrino.co) announces the collaboration with the LibreLink 1, 2 application, designed for Abbott’s FreeStyle Libre Flash Glucose Monitoring system.

AbbottABT recently announced the receipt of FDA approval for the FreeStyle Libre Flash glucose monitoring system in the United States. The approval is likely to widen this Illinois-based medical ...

The U.S. FDA recently approved Abbott Labs’ new blood glucose monitoring system – Freestyle Libre Flash. While this is a meaningful development for the company, it was expected. Abbott already markets ...